+ All Categories
Home > Documents > In Silico Protein Behavior

In Silico Protein Behavior

Date post: 01-Jan-2016
Category:
Upload: ginger-mcdowell
View: 50 times
Download: 0 times
Share this document with a friend
Description:
In Silico Protein Behavior. Predicting the Activity of p53 Tumor Suppressor Protein Mutants Using Features Derived From Homology Modeling. Sam Danziger Department of Biomedical Engineering University of California, Irvine. Dr. Rainer Brachmann School of Medicine. Dr. Richard Lathrop - PowerPoint PPT Presentation
Popular Tags:
14
In Silico In Silico Protein Protein Behavior Behavior Predicting the Activity of p53 Predicting the Activity of p53 Tumor Suppressor Protein Mutants Tumor Suppressor Protein Mutants Using Features Derived From Using Features Derived From Homology Modeling Homology Modeling Sam Danziger Department of Biomedical Engineering University of California, Irvine Dr. Rainer Brachmann School of Medicine Dr. Richard Lathrop School of Information and Computer Science Jue Zeng School of Medicine
Transcript
Page 1: In Silico Protein Behavior

In SilicoIn Silico Protein Protein BehaviorBehavior

Predicting the Activity of p53 Tumor Predicting the Activity of p53 Tumor Suppressor Protein Mutants Using Suppressor Protein Mutants Using Features Derived From Homology Features Derived From Homology

ModelingModeling

Sam DanzigerDepartment of Biomedical Engineering

University of California, Irvine

Dr. Rainer Brachmann

School of Medicine

Dr. Richard LathropSchool of Information and

Computer Science

Jue ZengSchool of Medicine

Page 2: In Silico Protein Behavior

What Am I DoingWhat Am I Doing: : Big PictureBig Picture

Biology Homology ModelingMake a protein

and test it in-vitro

PRO: Real

CON: Slow

Predict a protein

structure using a

template

PRO: Fast

CON: Inaccurate, so what does it tell us?

Machine

Learning

Use Homology

Modeling to guide

biological research

Page 3: In Silico Protein Behavior

What is p53?What is p53? Tumor Suppressor ProteinTumor Suppressor Protein p53 Mutations are present p53 Mutations are present

in ~50% of human cancers.in ~50% of human cancers. Receives upstream signals Receives upstream signals

in response to cellular in response to cellular stress.stress.

Arrests cell growth if there Arrests cell growth if there is repairable DNA damage.is repairable DNA damage.

Triggers apoptosis if DNA Triggers apoptosis if DNA damage is irreparable.damage is irreparable.

Second site mutations Second site mutations can rescue cancer can rescue cancer mutants.mutants. p53 core domain bound to DNA

Page 4: In Silico Protein Behavior

Rescue

Mutation

Cancer

Mutation

P53 Cancer Rescue P53 Cancer Rescue MutantsMutants

1) Healthy DNA |

Healthy P53

2a) Damaged DNA |

Inactive P53

3a) Damaged DNA |

Healthy P53

www.vh.org/adult/provider/pathology/OBGYNOncology/Images/Endo1.jpg

2b) Cancer

http://www.barrettsinfo.com/figures/cycle-p53.gif

3b) DNA Repair or Apoptosis

Page 5: In Silico Protein Behavior

What is Homology What is Homology Modeling?Modeling?

Modeling done using Amber™ with zinc ion characteristics tuned by Dr. Qiang Lu working in Dr. Ray Lui’s lab.Modeling done using Amber™ with zinc ion characteristics tuned by Dr. Qiang Lu working in Dr. Ray Lui’s lab.

1. Use a wild type crystal structure of the protein in question.

2. Substitute one or more amino acids to mutate the protein.

3. Apply simulated physical laws to determine an energy function.

4. Minimize the energy of the new mutant protein.

Page 6: In Silico Protein Behavior

How Do We Use Homology How Do We Use Homology Models?Models?

FF1111 FF1212 …… FF1n1n

3D p53 Molecule

2D Surface Map

Features from a grid

Page 7: In Silico Protein Behavior

What is Machine What is Machine Learning?Learning?

Training: Set the parameters with n features.

Testing: Use the parameters to predict unknown classes

WW11

WW22

……

WWnn

FF1111 FF1212 …… FF1n1n

FF2121 …… …… ……

…… …… …… ……

FFmm

11

…… …… FFmm

nn

Example 1Example 1

Example 2Example 2

……

Example mExample m

Class 1Class 1

Class 2Class 2

……

Class mClass m

Unknown Unknown FF1111 FF1212 …… FF1n1n

WW11

WW22

……

WWnn

PredictioPredictionn

Page 8: In Silico Protein Behavior

What do we know about What do we know about Rescue Mutants?Rescue Mutants?

261 mutants created 261 mutants created in-vitroin-vitro 5 sites for mutation = 5 sites for mutation =

194*193*192*191*190*19194*193*192*191*190*1955 = = 6.46 * 106.46 * 1017 17 possible mutantspossible mutants

We know 1 in every 2.47 * 10We know 1 in every 2.47 * 101515

It takes light about 1 month to go It takes light about 1 month to go 10101515 meters. meters. http://www.alcyone.com/max/physics/orders/metre.htmlhttp://www.alcyone.com/max/physics/orders/metre.html

Page 9: In Silico Protein Behavior

Where to look next?Where to look next?

Spiral Galaxy M101

http://hubblesite.org/

Known Mutants

Page 10: In Silico Protein Behavior

Let The Computer Pick The Let The Computer Pick The Next ExperimentsNext Experiments

1.1. Find interesting cancer rescue regions Find interesting cancer rescue regions by random sampling.by random sampling.

2.2. Focus the classifier on these regions Focus the classifier on these regions for detailed analysis.for detailed analysis.

3.3. Predict the behavior of putative rescue Predict the behavior of putative rescue mutants and create them mutants and create them in-vitroin-vitro..

4.4. Improve the classifier with knowledge Improve the classifier with knowledge about these new mutants.about these new mutants.

Page 11: In Silico Protein Behavior
Page 12: In Silico Protein Behavior

Ultimate GoalUltimate Goal

Broken p53

Engineered

Small Molecul

e

+ =

Functional Complex

Specific: Build models to understand how p53 breaks and help guide biological research by

mapping the space of p53 mutants.General: Build a generalized toolset to explore any protein

with functional mutations.

Intermediate Intermediate GoalsGoals

Page 13: In Silico Protein Behavior

AcknowledgmentsAcknowledgments

People:People: Pierre Baldi, Josh Swamidass, Pierre Baldi, Josh Swamidass, Richard Chamberlin, Jonathan Chen, Richard Chamberlin, Jonathan Chen, Jianlin Cheng, Melanie Cocco, Richard Jianlin Cheng, Melanie Cocco, Richard Colman, John Coroneus, Lawrence Colman, John Coroneus, Lawrence Dearth, Vinh Hoang, Qiang Lu, Hartmut Dearth, Vinh Hoang, Qiang Lu, Hartmut Luecke, Ray Luo, Hiroto Saigo, Don Luecke, Ray Luo, Hiroto Saigo, Don Senear, Ying WangSenear, Ying Wang

Funding:Funding: NIH, NSF, Harvey Fellowship NIH, NSF, Harvey Fellowship (JS), UCI Medical Scientist Training (JS), UCI Medical Scientist Training Program, UCI Office of Research and Program, UCI Office of Research and Graduate Studies, UCI Institute for Graduate Studies, UCI Institute for Genomics and BioinformaticsGenomics and Bioinformatics

Page 14: In Silico Protein Behavior

Questions?Questions?

1) Predictions

in silico

5) NewMutants

To Explore

2) Testsin vitro

4) NewTheories

3) Results ImprovePredictor

Thanks to Rainer Brachmann, Jue Zeng, Richard Thanks to Rainer Brachmann, Jue Zeng, Richard Lathrop, and everyone else who contributedLathrop, and everyone else who contributed


Recommended